CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company
FENNEC PHARMACEUTICALS INC.
Sign in to watch- Ticker
- FENC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (919) 636-4530
- Business address
- PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Former names
- ADHEREX TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,310,718
- in 4 filings, $1.2M under 10b5-1 plans
Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-25 | Andrade Robert CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −13,975 | $11.00 | $154K | 105,746 |
| 2024-01-05 | Andrade Robert CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −15,000 | $10.41 | $156K | 119,721 |
| 2024-01-04 | Andrade Robert CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −15,000 | $10.64 | $160K | 134,721 |
| 2023-12-28 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Option exercise | +8,540 | $1.59 | $14K | 291,127 |
| 2023-12-28 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Sale | −3,656 | $11.55 | $42K | 287,471 |
| 2023-12-28 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Option exercise · Commons Shares | +8,540 | $1.59 | $14K | 271,784 |
| 2023-12-26 | RALLIS CHRIS A Director | Sale 10b5-1 | −1,390 | $10.90 | $15K | 44,788 |
| 2023-12-26 | RALLIS CHRIS A Director | Option exercise 10b5-1 | +3,144 | $1.59 | $5K | 46,178 |
| 2023-12-26 | RALLIS CHRIS A Director | Option exercise · Common Shares 10b5-1 | −3,144 | $1.59 | $5K | 184,168 |
| 2023-11-20 | RALLIS CHRIS A Director | Sale 10b5-1 | −269 | $8.25 | $2K | 43,034 |
| 2023-11-16 | Islam Khalid Director | Option exercise | +133,333 | $2.31 | $308K | 133,333 |
| 2023-11-16 | Islam Khalid Director | Option exercise | +10,000 | $2.69 | $27K | 143,333 |
| 2023-11-16 | Islam Khalid Director | Option exercise | +50,000 | $1.13 | $57K | 193,333 |
| 2023-11-16 | Islam Khalid Director | Option exercise | +20,492 | $2.44 | $50K | 213,825 |
| 2023-11-16 | Islam Khalid Director | Option exercise · Common Shares | −133,333 | $2.31 | $308K | 255,492 |
| 2023-11-16 | Islam Khalid Director | Option exercise · Common Shares | −10,000 | $2.69 | $27K | 245,492 |
| 2023-11-16 | Islam Khalid Director | Option exercise · Common Shares | −50,000 | $1.13 | $57K | 195,492 |
| 2023-11-16 | Islam Khalid Director | Option exercise · Common Shares | −20,492 | $2.44 | $50K | 175,000 |
| 2023-11-08 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Sale | −17,049 | $7.69 | $131K | 290,582 |
| 2023-11-08 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Sale | −7,995 | $7.90 | $63K | 282,587 |
Page 16 of 17 · 340 trades